Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety
Status:
Unknown status
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and tolerability of the combination use of Passiflora incarnata L,
Crataegus oxyacantha and Salix alba L in mild and moderate anxiety.
Clinical study phase III, multicenter, prospective, open.
Patients will be included in sufficient quantity to achieve the minimum number of 124
evaluable patients.